Sein

TITRE (EN) Breast Cancer Plasma Adjuvant Intra-operative Treatment
PROTOCOLE ID Breast Cancer PAINT
CLINICAL TRIAL.gov ID NCT06222788
TYPE(S) DE CANCER Sein
PHASE Autres
TYPE D'ÉTUDE Clinique
INSTITUTION CHUM
1051 rue Sanguinet
(514) 890-8000
VILLE Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E) Philip Wong
COORDONATEUR(RICE) Ana Lydia Tkalec
grcs.chum@ssss.gouv.qc.ca
514-890-8000 poste 14186
STATUT  Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ (EN)
  • Age ≥18 years at the time of signing study consent.
  • ECOG ≤2.
  • Patient with T1-4 breast cancer for groups A and B; patient with T1/T2 breast cancer for group C (based on physical exam, not radiological measurements).
  • Patient is scheduled to undergo a lumpectomy.
CRITÈRES D'EXCLUSION (EN)
  • Prior treatment for the tumor of interest (including chemotherapy, immunotherapy, radiotherapy).
  • Patient planning to or undergoing intraoperative radiotherapy.
  • Diabetes (types I and II).
  • Hypercortisolism.
  • Collagen vascular disease.
  • Patient requiring systemic corticosteroids at physiologic doses exceeding 10 mg/day of prednisone or its equivalent.
  • Patient receiving daily chemotherapy for rheumatological conditions.
  • Pregnancy (a urine pregnancy test must be obtained for non-sterile women of childbearing potential prior to surgery).